Stoke Therapeutics Ratios and Metrics

Market cap in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Year	Current	2023	2022	2021	2020	2019
Market Capitalization	618	235	364	883	2,073	927
Market Cap Growth	-	-35.46%	-58.77%	-57.42%	123.63%	-
Enterprise Value	399	33	134	662	1,785	704
PE Ratio	-2.24	-2.24	-3.60	-10.29	-39.68	-28.67
PS Ratio	68.50	26.75	29.34	-	-	-
PB Ratio	3.77	1.47	1.97	4.05	7.25	4.13
P/FCF Ratio	-2.84	-2.84	-10.16	-12.96	-47.90	-28.36
P/OCF Ratio	-2.90	-2.90	-11.42	-13.19	-49.09	-29.85
EV/Sales Ratio	45.50	3.75	10.78	-	-	-
EV/EBITDA Ratio	-0.30	-0.30	-1.33	-7.91	-35.98	-22.09
EV/EBIT Ratio	-0.29	-0.29	-1.28	-7.71	-34.64	-21.79
EV/FCF Ratio	-0.40	-0.40	-3.73	-9.72	-41.26	-21.54
Quick Ratio	6.55	6.55	7.33	12.86	25.17	54.30
Current Ratio	6.99	6.99	7.77	13.37	25.73	55.12
Asset Turnover	0.04	0.04	0.04	0	0	0
Interest Coverage	-	-	-	-	-73.63	-
Return on Equity (ROE)	-56.90%	-56.90%	-47.40%	-34.90%	-23.30%	-16.20%
Return on Assets (ROA)	-41.60%	-41.60%	-35.10%	-33.10%	-22.50%	-15.80%
Return on Capital (ROIC)	-71.93%	-71.93%	-56.45%	-39.52%	-18.54%	-15.90%
Earnings Yield	-17.41%	-44.58%	-27.77%	-9.72%	-2.52%	-3.49%
FCF Yield	-13.75%	-35.20%	-9.84%	-7.72%	-2.09%	-3.53%
Buyback Yield / Dilution	-13.10%	-13.10%	-5.87%	-9.71%	-86.34%	-2433.56%
Total Shareholder Return	-13.10%	-13.10%	-5.87%	-9.71%	-86.34%	-2433.56%

Source: Financials are provided by Nasdaq Data Link and sourced from the audited annual (10-K) and quarterly (10-Q) reports submitted to the Securities and Exchange Commission (SEC).